Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

Clinical trial NCT01074268 · COMPLETED

Trial details

NCT number: NCT01074268
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Diabetes Mellitus, Type 1

Start date: 2010-02-01
Primary completion: 2010-12-01
Enrollment: 456

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.